415 related articles for article (PubMed ID: 32731615)
1. Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications.
Tesarova L; Jaresova K; Simara P; Koutna I
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731615
[TBL] [Abstract][Full Text] [Related]
2. Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord.
Thaweesapphithak S; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Roytrakul S; Manochantr S
Stem Cell Res Ther; 2019 Mar; 10(1):79. PubMed ID: 30845980
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor modulates cell cycle of human umbilical cord-derived mesenchymal stem cells.
Ramasamy R; Tong CK; Yip WK; Vellasamy S; Tan BC; Seow HF
Cell Prolif; 2012 Apr; 45(2):132-9. PubMed ID: 22309282
[TBL] [Abstract][Full Text] [Related]
4. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation.
Cutler AJ; Limbani V; Girdlestone J; Navarrete CV
J Immunol; 2010 Dec; 185(11):6617-23. PubMed ID: 20980628
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition.
Ma J; Wu J; Han L; Jiang X; Yan L; Hao J; Wang H
Stem Cell Res Ther; 2019 Jan; 10(1):19. PubMed ID: 30635045
[TBL] [Abstract][Full Text] [Related]
6. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
Front Immunol; 2021; 12():686356. PubMed ID: 34484183
[TBL] [Abstract][Full Text] [Related]
7. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.
Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK
Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 modulates immunosuppressive ability and cellular senescence of human umbilical cord mesenchymal stem cells.
Jie Z; Huan Y; Mengyun W; Yasha L; Huafeng P; Ke Y
Biochem Biophys Res Commun; 2020 Jun; 526(4):1021-1027. PubMed ID: 32317184
[TBL] [Abstract][Full Text] [Related]
9. Differential Development of Umbilical Cord-Derived Mesenchymal Stem Cells During Long-Term Maintenance in Fetal Bovine Serum-Supplemented Medium and Xeno- and Serum-Free Culture Medium.
Le HM; Nguyen LT; Hoang DH; Bach TQ; Nguyen HTN; Mai HT; Trinh DP; Nguyen TD; Nguyen LT; Than UTT
Cell Reprogram; 2021 Dec; 23(6):359-369. PubMed ID: 34748399
[TBL] [Abstract][Full Text] [Related]
10. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells.
Mennan C; Garcia J; Roberts S; Hulme C; Wright K
Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254
[TBL] [Abstract][Full Text] [Related]
12. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
14. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
[TBL] [Abstract][Full Text] [Related]
16. Neurosphere formation enhances the neurogenic differentiation potential and migratory ability of umbilical cord-mesenchymal stromal cells.
Mukai T; Nagamura-Inoue T; Shimazu T; Mori Y; Takahashi A; Tsunoda H; Yamaguchi S; Tojo A
Cytotherapy; 2016 Feb; 18(2):229-41. PubMed ID: 26794714
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
18. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis.
Zheng J; Li H; He L; Huang Y; Cai J; Chen L; Zhou C; Fu H; Lu T; Zhang Y; Yao J; Yang Y
Cell Prolif; 2019 Mar; 52(2):e12546. PubMed ID: 30537044
[TBL] [Abstract][Full Text] [Related]
20. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
